1. Assessing the need for routine safety testing for patients being treated with dupilumab for moderate‐to‐severe atopic dermatitis. (1st June 2020) Authors: Wollenberg, A; Beck, L.A.; Blauvelt, A.; Simpson, E.L.; Chen, Z.; Chen, Q.; Shumel, B.; Khokhar, F.A.; Hultsch, T.; Rizova, E.; Rossi, A.B.; Graham, N.M.H.; Pirozzi, G.; Lu, Y.; Ardeleanu, M. Journal: British journal of dermatology Issue: Volume 182:Number 6(2020) Page Start: e186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Conjunctivitis in dupilumab clinical trials. (1st September 2019) Authors: Akinlade, B.; Guttman‐Yassky, E.; de Bruin‐Weller, M.; Simpson, E.L.; Blauvelt, A.; Cork, M.J.; Prens, E.; Asbell, P.; Akpek, E.; Corren, J.; Bachert, C.; Hirano, I.; Weyne, J.; Korotzer, A.; Chen, Z.; Hultsch, T.; Zhu, X.; Davis, J.D.; Mannent, L.; Hamilton, J.D. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: e69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Conjunctivitis in dupilumab clinical trials. (7th May 2019) Authors: Akinlade, B.; Guttman‐Yassky, E.; de Bruin‐Weller, M.; Simpson, E.L.; Blauvelt, A.; Cork, M.J.; Prens, E.; Asbell, P.; Akpek, E.; Corren, J.; Bachert, C.; Hirano, I.; Weyne, J.; Korotzer, A.; Chen, Z.; Hultsch, T.; Zhu, X.; Davis, J.D.; Mannent, L.; Hamilton, J.D. Journal: British journal of dermatology Issue: Volume 181:Number 3(2019) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin‐17 levels?: reply from the authors. (1st May 2018) Authors: de Bruin‐Weller, M.; Graham, N.M.H.; Pirozzi, G.; Shumel, B. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: 1220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin‐17 levels?: reply from the authors. (2nd March 2018) Authors: de Bruin‐Weller, M.; Graham, N.M.H.; Pirozzi, G.; Shumel, B. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: 1220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials. (2nd January 2022) Authors: Barbarot, S.; Wollenberg, A.; Silverberg, J. I.; Deleuran, M.; Pellacani, G.; Armario-Hita, J. C.; Chen, Z.; Shumel, B.; Eckert, L.; Gadkari, A.; Lu, Y.; Rossi, A. B. Journal: Journal of dermatological treatment Issue: Volume 33:Number 1(2022) Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ). (16th May 2018) Authors: de Bruin‐Weller, M.; Thaçi, D.; Smith, C.H.; Reich, K.; Cork, M.J.; Radin, A.; Zhang, Q.; Akinlade, B.; Gadkari, A.; Eckert, L.; Hultsch, T.; Chen, Z.; Pirozzi, G.; Graham, N.M.H.; Shumel, B. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: e366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)4. (25th March 2018) Authors: de Bruin‐Weller, M.; Thaçi, D.; Smith, C.H.; Reich, K.; Cork, M.J.; Radin, A.; Zhang, Q.; Akinlade, B.; Gadkari, A.; Eckert, L.; Hultsch, T.; Chen, Z.; Pirozzi, G.; Graham, N.M.H.; Shumel, B. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ). (1st May 2018) Authors: de Bruin‐Weller, M.; Thaçi, D.; Smith, C.H.; Reich, K.; Cork, M.J.; Radin, A.; Zhang, Q.; Akinlade, B.; Gadkari, A.; Eckert, L.; Hultsch, T.; Chen, Z.; Pirozzi, G.; Graham, N.M.H.; Shumel, B. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo‐controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ). (1st May 2018) Authors: de Bruin‐Weller, M.; Thaçi, D.; Smith, C.H.; Reich, K.; Cork, M.J.; Radin, A.; Zhang, Q.; Akinlade, B.; Gadkari, A.; Eckert, L.; Hultsch, T.; Chen, Z.; Pirozzi, G.; Graham, N.M.H.; Shumel, B. Journal: British journal of dermatology Issue: Volume 178:Number 5(2018) Page Start: e366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗